[Report] 2019 Market Research Report: The Use of Virtual Components in Clinical Trials

Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual." In collaboration with CNS Summit, Oracle Health Sciences met with industry stakeholders to get clarity on the following questions:

  • How does the industry define "decentralized"or "virtual" trials?
  • What problems do virtual trials solve?
  • What are the challenges of virtual trials?
  • What does the future hold for virtual trials?


Sponsored by: